Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvan Jamilloux

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Blood|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Marcela A Ferrada, Matthew J Koster, et al.
The Journal of Experimental Medicine|February 19, 2021
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophagesOmmar Omarjee, Anne-Laure Mathieu, Gaëlle Quiniou, et al.
Rheumatology (Oxford, England)|March 20, 2019
Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patientsCécile-Audrey Durel, Arnaud Hot, Ludovic Trefond, et al.
The Journal of Experimental Medicine|December 3, 2025
SpeckSeq enables high-throughput functional stratification of MEFV variants in autoinflammatory diseasesPauline Bronnec, Sarah Dalmon, Chloe Briand, et al.
Autoimmunity Reviews|February 11, 2018
Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis)Pierre Grumet, Laurent Kodjikian, Audrey de Parisot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Distinct natural killer cell signature in still's disease: Insights from a multinational immunome project consortium for autoinflammatory disordersAmber De Visscher, Jarne Beliën, Bert Malengier-Devlies, et al.
The Journal of Experimental Medicine|March 26, 2024
Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammationCamille Cosson, Romane Riou, Danish Patoli, et al.
Annals of the Rheumatic Diseases|September 24, 2024
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's diseaseBruno Fautrel, Stéphane Mitrovic, Arianna De Matteis, et al.
EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.
Chest|October 22, 2022
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) SyndromeRaphael Borie, Marie Pierre Debray, Alexis F Guedon, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Blood|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter studyMaël Heiblig, Marcela A Ferrada, Matthew J Koster, et al.
The Journal of Experimental Medicine|February 19, 2021
LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophagesOmmar Omarjee, Anne-Laure Mathieu, Gaëlle Quiniou, et al.
Rheumatology (Oxford, England)|March 20, 2019
Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patientsCécile-Audrey Durel, Arnaud Hot, Ludovic Trefond, et al.
The Journal of Experimental Medicine|December 3, 2025
SpeckSeq enables high-throughput functional stratification of MEFV variants in autoinflammatory diseasesPauline Bronnec, Sarah Dalmon, Chloe Briand, et al.
Autoimmunity Reviews|February 11, 2018
Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis)Pierre Grumet, Laurent Kodjikian, Audrey de Parisot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 9, 2025
Distinct natural killer cell signature in still's disease: Insights from a multinational immunome project consortium for autoinflammatory disordersAmber De Visscher, Jarne Beliën, Bert Malengier-Devlies, et al.
The Journal of Experimental Medicine|March 26, 2024
Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammationCamille Cosson, Romane Riou, Danish Patoli, et al.
Annals of the Rheumatic Diseases|September 24, 2024
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's diseaseBruno Fautrel, Stéphane Mitrovic, Arianna De Matteis, et al.
EMBO Molecular Medicine|June 17, 2026
Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndromeMartin Killian, Suzanne K Shoffner-Beck, Timon Damelang, et al.
Chest|October 22, 2022
Pleuropulmonary Manifestations of Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) SyndromeRaphael Borie, Marie Pierre Debray, Alexis F Guedon, et al.
Pageof 16